In 2008 pharmaceutical agents low-profit era with the safe operation of the market.docVIP

  • 3
  • 0
  • 约5.53千字
  • 约 5页
  • 2017-05-03 发布于浙江
  • 举报

In 2008 pharmaceutical agents low-profit era with the safe operation of the market.doc

In 2008 pharmaceutical agents low-profit era with the safe operation of the market

 PAGE \* MERGEFORMAT 5 In 2008 pharmaceutical agents ‘low-profit era’ with the safe operation of the market I (Beijing Beat From EMKT. training Albert Pharmaceutical Marketing Ltd chairman, the training division Yuefeng) recently for the two pharmaceutical companies (one is the traditional Chinese medicine production enterprises, a medical device company) agent to do the annual training , it is Coincidentally, the two companies to do the topic is almost similar, that is, how to conduct their own agents to receive ‘low-profit era of’ the arrival of the fact that change in the way of profits and tax receipts to achieve the security issues resolved, and how ‘safe’ implementation of product promotion in clinical practice, and so on.I believe that both the high-level agents, or pharmaceutical companies will undoubtedly be a high degree of attention to these issues, in this writer on these issues to share with you my views. Its current form, the emergence of patterns of pharmaceutical agents have at least 10 years of time, the main manifestations are: the reserve price cash delivery, the local affiliated business firms to achieve drug legitimate business, most of the profits achieved on the ground, in order to boost profits, some agents to take buy a ticket for votes and other means to achieve tax avoidance, in today’s tax laws become more perfect; and Guangdong ‘hanging net tender’ request ‘two-vote system’ is proposed; commercial companies through capital restructuring or mergers and acquisitions and other means of making the future of the regional flow of business companies are increasingly a high degree of centralization, in 2007 where a number of the company’s circle of small and medium pharmaceutical business models to abscond, or M amp;amp; A proof of this point. So, if the pharmaceutical agents to stick to the predictable result is: you can for votes companies are increasingly hard to find, or cooperative conditions more stringent than ever before, or to i

文档评论(0)

1亿VIP精品文档

相关文档